Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin
Mehmet Kurtoğlu(Istanbul University), Volkan Granit(Biohaven Pharmaceuticals (United States)), Dincay Buyukkurt(Istanbul University), Sevda Kizilirmak(Istanbul University), Hakan Yanar(Istanbul University), Recep Güloğlu(Istanbul University), Yılmaz Bilsel(Haydarpaşa Numune Eğitim ve Araştırma Hastanesi)
Cited by 149
Related Papers
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
|The Lancet Neurology|2023|255
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
|Neurology|2020|201
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
|Brain|2021|116
Predicting Outcome in Guillain-Barré Syndrome
|Neurology|2021|67